Name & Company Information Location Interests Events
user-icon

Cat Davis Ahmed

The FH Foundation

Vice President, Policy and Outreach

Pasadena

United States

IP10: PRIOR AUTHORIZATION POLICIES FOR MANAGING SPECIALTY DRUG SPENDING IN THE UNITED STATES: CAN WE STRIKE A BALANCE BETWEEN APPROPRIATE UTILIZATION AND APPROPRIATE ACCESS?
0_07OU4rI0-9bFTVSemWiYdAcVh9oI5ZCwIQGgWmIMKQRSqN3IeYGZZEwM3EbI5VSemji4JBoptxIw9W3wDX7qfIExLxII9WreeX7Msrn0K5sG9OT3e8xZyTfr21

Amine Aissaoui

Paris Dauphine University, PSL

Researcher

Paris

France

W7: ARTIFICIAL INTELLIGENCE AND PRECISION MEDICINE: DOES THE HEALTH ECONOMIST NEED TO ADAPT TO THE MACHINE?
Alfonso_Rafael

Rafael Alfonso-Cristancho

GSK Consumer Care

Senior Director

Collegeville

United States

IP21: IS ARTIFICIAL INTELLIGENCE THE NEXT BIG THING IN HEALTHCARE DECISION MAKING?
0

Omar Ali

NICE

Pharmacy Director

London

United Kingdom

Economic Outcomes, Patient-Centered Outcomes W17: DO CUTTING-EDGE ONE-TIME TREATMENTS NEED EQUALLY INNOVATIVE-, OUTCOMES-, OR ANNUITY-BASED PAYMENT MODELS?
Ambegaonkar_Ambarish

Ambarish J. Ambegaonkar

APPERTURE LLC

Founder and Managing Partner

Marlboro

United States

Economic and Financial Drivers of Value Focus and Development of a Holistic Value Proposition
Augustovski_Federico_2016

Federico Augustovski

(IECS) Institute for Clinical Effectiveness and Health Policy

Director, HTA

Buenos Aires

Argentina

INCOMING PRESIDENTIAL ADDRESS
Barsdorf_Alexandra

Alexandra Barsdorf

Pfizer, Inc

Director, Outcomes & Evidence

New York

United States

Clinical Outcomes, Economic Outcomes, Outcomes Research Methods, Patient-Centered Outcomes, Use Of Outcomes Research Introduction to Patient Reported Outcomes
Anirban_Basu

Dr Anirban Basu

University of Washington

Stergachis Family Endowed Professor & Director

Seattle

United States

F6: VALUE OF INFORMATION (VOI) ANALYSIS FOR RESEARCH DECISIONS EMERGING GOOD PRACTICES TASK FORCE: FINAL RECOMMENDATIONS
user-icon

Katy Benjamin

AbbVie Inc

Director

Chicago

United States

IP23: ESTIMATING SAMPLE SIZE FOR QUALITATIVE RESEARCH IN CLINICAL OUTCOME ASSESSMENT RESEARCH: ONE SIZE DOES NOT FIT ALL!
user-icon

Nancy Berg

-
user-icon

Marc Berger

Self Employed

Consultant

New York

United States

EDUCATIONAL SYMPOSIUM: DEBATING THE FUTURE OF HEALTHCARE, IP16: IN THE ELECTRONIC HEALTH RECORD ERA, DO WE STILL NEED CLINICAL REGISTRIES?
user-icon

Jasmine Bihm

Agency for Healthcare Research and Quality (AHRQ)

Staff Fellow

Rockville

United States

W3: DIGITAL HEALTH: EVALUATING THE EVIDENCE, IDENTIFYING GAPS, PRODUCING BETTER SCIENCE
JBB_shot2

Jakob Bjorner

Optum Patients Insights

Chief Science Officer

Johnston

United States

W20: FIXING THE TOWER OF BABEL: ESTABLISHING A COMMON METRIC FOR PATIENT-REPORTED OUTCOME MEASURES
user-icon

Kathleen Blake

American Medical Association (AMA)

Vice President, Healthcare Quality

Washington

United States

IP7: THE CHANGING LANDSCAPE OF HEALTHCARE DECISION MAKING: HOW CAN WE LEVERAGE THE USE OF REAL-WORLD EVIDENCE FOR REGULATORY, COVERAGE, AND CLINICAL DECISION MAKING?
user-icon

Michael Blum

U.S. Food & Drug Administration

Deputy Director

Silver Spring

United States

W4: BIOSIMILARS, UTILIZATION, AND POST-MARKETING SURVEILLANCE IN THE UNITED STATES (Invited Workshop)
Brazier_John

John Brazier

University of Sheffield

Dean

Sheffield

United Kingdom

Utility Measures, F1: HEALTH STATE UTILITY (HSU) GOOD PRACTICES TASK FORCE RECOMMENDATIONS FOR IDENTIFICATION AND USE OF HSU DATA IN COST-EFFECTIVENESS IN DECISION MODELLING, P15: UTILITY AND PATIENT PREFERENCE STUDIES
Briggs-Andrew

Andrew Briggs

Health Economics and Health Technology Assessment, University of Glasgow

Professor of Health Economics

Glasgow

United Kingdom

Collecting Health-State Utility Estimates for Economic Models in Clinical Studies, Advanced Decision Modeling for Health Economic Evaluations, IP3: THE MACHINE LEARNING DEBATE: PANACEA OR THE NEW ALCHEMY?, P9: HEALTH TECHNOLOGY ASSESSMENT STUDIES
Brixner_Diana

Diana Brixner

University of Utah

Professor, Department of Pharmacotherapy, University of Utah College of Pharmacy

Salt Lake City

United States

Clinical Outcomes, Economic Outcomes, Outcomes Research Methods, Patient-Centered Outcomes, Use Of Outcomes Research In Decisions Applications in Using Large Databases, EDUCATIONAL SYMPOSIUM: HEALTHCARE GRIDLOCK BETWEEN VALUE, AFFORDABILITY, AND ACCESS: THE GOOD, THE BAD AND THE UGLY
Brodtkorb-Thor-Henrik

Thor-Henrik Brodtkorb

RTI Health Solutions

Senior Director, Health Economics

Ljungskile

Sweden

Budget Impact Analysis II – Applications and Design Issues
brogan_anita

Anita Brogan

RTI Health Solutions

Head

Manchester

United Kingdom

Economic Outcomes, Outcomes Research Methods, Use Of Outcomes Research Budget Impact Analysis II – Applications and Design Issues